| Followers | 2543 |
| Posts | 250731 |
| Boards Moderated | 34 |
| Alias Born | 05/06/2014 |
Friday, September 08, 2017 1:52:02 AM
$PMCB Phase 1 - Pharmacyte Biotech Inc research using Melligen Cells PMCB
Project Member(s):
Simpson, A.
Funding or Partner Organisation:
Pharmacyte Biotech Inc
Start year:
2015
Summary:
This is a first phase engagement with Pharmacyte Biotech Inc (a US based cell therapy company formerly known as Nuvilex) around investigating the in vitro and in vivo performance of UTS technology (Melligen Cells for diabetes treatment) once encapsulated. Future phases may result in more detailed in vitro and in vivo studies investigating the encapsulated Melligen cells.
Pharmacyte, Pharmacyte Biotech, Nuvilex, Melligen, Diabetes, Simpson
Regenerative Medicine (incl. Stem Cells and Tissue Engineering), Diabetes
http://cfsites1.uts.edu.au/find/projects/detail.cfm?ProjectId=2014000473
Project Member(s):
Simpson, A.
Funding or Partner Organisation:
Pharmacyte Biotech Inc
Start year:
2015
Summary:
This is a first phase engagement with Pharmacyte Biotech Inc (a US based cell therapy company formerly known as Nuvilex) around investigating the in vitro and in vivo performance of UTS technology (Melligen Cells for diabetes treatment) once encapsulated. Future phases may result in more detailed in vitro and in vivo studies investigating the encapsulated Melligen cells.
Pharmacyte, Pharmacyte Biotech, Nuvilex, Melligen, Diabetes, Simpson
Regenerative Medicine (incl. Stem Cells and Tissue Engineering), Diabetes
http://cfsites1.uts.edu.au/find/projects/detail.cfm?ProjectId=2014000473
investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
